Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.539, 2007-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Moxifloxacin, nonstandardised antibacterials equivalent in CAP
Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. :
Access to resources
Recommend
Moxifloxacin tops in CAP regardless of resistance level
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :
Moxifloxacin monotherapy on par with combination therapy in CAP
Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. :
Moxifloxacin: sequential therapy produces rapid improvements in CAP
Inpharma, Vol. 1, Iss. 1440, 2004-01 ,pp. :
Moxifloxacin IV-to-oral switch proves cost effective in patients with CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. :